CN111328949A - 一种b族维生素组合物固体饮料 - Google Patents
一种b族维生素组合物固体饮料 Download PDFInfo
- Publication number
- CN111328949A CN111328949A CN201811555759.0A CN201811555759A CN111328949A CN 111328949 A CN111328949 A CN 111328949A CN 201811555759 A CN201811555759 A CN 201811555759A CN 111328949 A CN111328949 A CN 111328949A
- Authority
- CN
- China
- Prior art keywords
- vitamin
- solid beverage
- acid
- oligosaccharide
- fructo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000019156 vitamin B Nutrition 0.000 title claims abstract description 40
- 239000011720 vitamin B Substances 0.000 title claims abstract description 40
- 235000013361 beverage Nutrition 0.000 title claims abstract description 21
- 239000007787 solid Substances 0.000 title claims abstract description 16
- 239000000203 mixture Substances 0.000 title claims abstract description 14
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims abstract description 33
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 30
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims abstract description 24
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims abstract description 16
- 235000019152 folic acid Nutrition 0.000 claims abstract description 16
- 239000011724 folic acid Substances 0.000 claims abstract description 16
- 229960000304 folic acid Drugs 0.000 claims abstract description 16
- 239000001509 sodium citrate Substances 0.000 claims abstract description 16
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims abstract description 16
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims abstract description 14
- 229940107187 fructooligosaccharide Drugs 0.000 claims abstract description 14
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims abstract description 13
- 235000019161 pantothenic acid Nutrition 0.000 claims abstract description 12
- 239000011713 pantothenic acid Substances 0.000 claims abstract description 12
- 229940055726 pantothenic acid Drugs 0.000 claims abstract description 12
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims abstract description 12
- 235000021552 granulated sugar Nutrition 0.000 claims abstract description 11
- 239000005913 Maltodextrin Substances 0.000 claims abstract description 10
- 229920002774 Maltodextrin Polymers 0.000 claims abstract description 10
- 229940035034 maltodextrin Drugs 0.000 claims abstract description 10
- 239000002994 raw material Substances 0.000 claims abstract description 10
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims abstract description 9
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims abstract description 7
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims abstract description 7
- 229960002477 riboflavin Drugs 0.000 claims abstract description 7
- 229960003495 thiamine Drugs 0.000 claims abstract description 7
- 229930003451 Vitamin B1 Natural products 0.000 claims abstract description 6
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 claims abstract description 6
- 235000010374 vitamin B1 Nutrition 0.000 claims abstract description 6
- 239000011691 vitamin B1 Substances 0.000 claims abstract description 6
- 229940011671 vitamin b6 Drugs 0.000 claims abstract description 6
- 229930003779 Vitamin B12 Natural products 0.000 claims abstract description 5
- 229930003471 Vitamin B2 Natural products 0.000 claims abstract description 5
- 235000019163 vitamin B12 Nutrition 0.000 claims abstract description 5
- 239000011715 vitamin B12 Substances 0.000 claims abstract description 5
- 235000019164 vitamin B2 Nutrition 0.000 claims abstract description 5
- 239000011716 vitamin B2 Substances 0.000 claims abstract description 5
- 235000019158 vitamin B6 Nutrition 0.000 claims abstract description 5
- 239000011726 vitamin B6 Substances 0.000 claims abstract description 5
- 229960004106 citric acid Drugs 0.000 claims abstract description 3
- 235000015165 citric acid Nutrition 0.000 claims abstract description 3
- 229960001790 sodium citrate Drugs 0.000 claims abstract description 3
- 235000011083 sodium citrates Nutrition 0.000 claims abstract description 3
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims abstract 2
- 229930003270 Vitamin B Natural products 0.000 claims description 21
- 239000004480 active ingredient Substances 0.000 claims description 4
- 235000019640 taste Nutrition 0.000 abstract description 9
- 230000006870 function Effects 0.000 abstract description 6
- 235000016709 nutrition Nutrition 0.000 abstract description 6
- 230000035764 nutrition Effects 0.000 abstract description 6
- 230000036541 health Effects 0.000 abstract description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 abstract 1
- 229930006000 Sucrose Natural products 0.000 abstract 1
- 229940088594 vitamin Drugs 0.000 description 26
- 229930003231 vitamin Natural products 0.000 description 26
- 235000013343 vitamin Nutrition 0.000 description 26
- 239000011782 vitamin Substances 0.000 description 26
- 150000003722 vitamin derivatives Chemical class 0.000 description 20
- 239000000126 substance Substances 0.000 description 7
- 230000000694 effects Effects 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 6
- JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 5
- 210000001035 gastrointestinal tract Anatomy 0.000 description 5
- 239000003925 fat Substances 0.000 description 4
- 235000020510 functional beverage Nutrition 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 230000004060 metabolic process Effects 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 230000010261 cell growth Effects 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000032823 cell division Effects 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- NHZMQXZHNVQTQA-UHFFFAOYSA-N pyridoxamine Chemical compound CC1=NC=C(CO)C(CN)=C1O NHZMQXZHNVQTQA-UHFFFAOYSA-N 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 235000019192 riboflavin Nutrition 0.000 description 2
- 239000002151 riboflavin Substances 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 206010002065 Anaemia megaloblastic Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000000913 Kidney Calculi Diseases 0.000 description 1
- 208000000682 Megaloblastic Anemia Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010029148 Nephrolithiasis Diseases 0.000 description 1
- 206010029240 Neuritis Diseases 0.000 description 1
- 241000208125 Nicotiana Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 208000031845 Pernicious anaemia Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000005107 Premature Birth Diseases 0.000 description 1
- 206010036590 Premature baby Diseases 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical group C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 1
- 229930003571 Vitamin B5 Natural products 0.000 description 1
- 229930003761 Vitamin B9 Natural products 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 231100000176 abortion Toxicity 0.000 description 1
- 206010000210 abortion Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000001919 adrenal effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 208000003464 asthenopia Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000004098 cellular respiration Effects 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000010437 erythropoiesis Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 235000013332 fish product Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 230000005176 gastrointestinal motility Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000016784 immunoglobulin production Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000013016 learning Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 231100000533 low birth weight Toxicity 0.000 description 1
- 208000018773 low birth weight Diseases 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000036244 malformation Effects 0.000 description 1
- 231100001016 megaloblastic anemia Toxicity 0.000 description 1
- 230000008558 metabolic pathway by substance Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000000276 neural tube Anatomy 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 235000014059 processed cheese Nutrition 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 229960003581 pyridoxal Drugs 0.000 description 1
- 235000008164 pyridoxal Nutrition 0.000 description 1
- 239000011674 pyridoxal Substances 0.000 description 1
- 235000008151 pyridoxamine Nutrition 0.000 description 1
- 239000011699 pyridoxamine Substances 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000019614 sour taste Nutrition 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 235000009492 vitamin B5 Nutrition 0.000 description 1
- 239000011675 vitamin B5 Substances 0.000 description 1
- 235000019159 vitamin B9 Nutrition 0.000 description 1
- 239000011727 vitamin B9 Substances 0.000 description 1
- 229940046001 vitamin b complex Drugs 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/60—Sweeteners
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/68—Acidifying substances
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
本发明公开了一种B族维生素组合物固体饮料，将维生素B1、维生素B2、维生素B6、维生素B12、泛酸、叶酸、柠檬酸、柠檬酸钠、麦芽糊精、低聚果糖、白砂糖等各种原料按比例混合在容器中，混合均匀，既得本发明成品。本发明制备的B族维生素组合物固体饮料营养丰富，功能多样，涵盖了人体所需的大部分B族维生素，该复合维生素既能保健，又能提高人体抵抗力，所采用VB比例，精确设计，有效提高了成人对VB的综合利用，从而提高了保健价值。本固体饮料通过柠檬酸钠、低聚果糖和白砂糖等调节口味，可在不影响破坏营养的基础上有效改善味道，口感较好。
Description
技术领域
本发明涉及食品、医药技术领域，具体地，涉及一种B族维生素组合物固体饮料。
背景技术
维生素是维持身体健康所必需的一类有机化合物。这类物质在体内既不能是构成身体组织的原料，也不是能量的来源，而是一类调节物质，在物质代谢中起重要作用。
维生素B族有十二种以上，被世界一致公认的有九种，全是水溶性维生素，在体内滞留的时间只有数小时，必须每天补充。维生素B包括维生素B1、维生素B2、维生素B6、维生素B12、烟酸、泛酸、叶酸等。这些B族维生素是推动体内代谢，把糖、脂肪、蛋白质等转化成热量时不可缺少的物质。如果体内维生素B的含量充足，就可以缓解紧张、忧虑的情绪，并且可以提高对于噪音的承受力。有助于胃肠蠕动，缓解便秘的症状。所有的维生素B必须同时发挥作用，称为VB的融合作用。单独摄入某种VB，由于细胞的活动增加，从而使对其它VB的需求跟着增加，所以各种VB的作用是相辅相成的。因此补充VB使用复合维生素B具有很好的效果。
维生素饮料是指通过调整饮料中营养素(营养成分为各种维生素组成)的成分和含量比例，在一定程度上调节人体功能的饮料，现在消费者也称为维生素饮料。从目前的市场行情来看，维生素功能饮料国内品牌力量薄弱，国外品牌价格居高不下，造成消费者爱喝却喝不起的现象，近年来，功能饮料国内品牌成长迅速。相信不远的将来，在市场份额上，国内维生素功能饮料必将赶超国外维生素功能饮料。尤其是那些富含维生素、矿物质、氨基酸等营养成分的固体饮料，可以及时补充人体代谢所需营养，将成为人们生活中离不开的好伴侣。
发明内容
本发明所要解决的技术问题是提供一种B族维生素组合物固体饮料。本发明所公开的一种B族维生素组合物固体饮料营养丰富，功能多样，涵盖了人体所需的大部分B族维生素，其中的活性成分均为人体必须的物质，该复合维生素既能保健，又能提高人体抵抗力，所采用VB比例，精确设计，充分考虑了日常饮食中的正常摄取量，符合人体需要，有效提高了成人对VB的综合利用，从而提高了保健价值。
本发明解决上述技术问题所采用的技术方案是，一种B族维生素组合物固体饮料，该组合物含有以下活性成分：
维生素B1、维生素B2、维生素B6、维生素B12、泛酸、叶酸、柠檬酸、柠檬酸钠、麦芽糊精、低聚果糖、白砂糖。
进一步的技术方案中，所述配方由以下重量份数的原料组成：维生素B1 0.5-1.5mg、维生素B2 0.6-1.85mg、维生素B6 0.2-0.6mg、维生素B12 0.02-0.15mg、泛酸0.1-0.25mg、叶酸0.02-0.15mg、柠檬酸11.2-19.5mg、柠檬酸钠3-8mg、麦芽糊精0.3-0.6mg、低聚果糖2-8mg、白砂糖50-120mg。
进一步的技术方案中，所述配方由以下重量份数的原料组成：维生素B1 0.5-1mg、维生素B2 0.8-1.2mg、维生素B6 0.2-0.5mg、维生素B12 0.02-0.06mg、泛酸0.1-0.2mg、叶酸0.02-0.04mg、柠檬酸12-15mg、柠檬酸钠4-6mg、麦芽糊精0.4-0.5mg、低聚果糖5-7mg、白砂糖80-100mg。
本发明方案的技术原理为：
(1)维生素B1：又称硫胺素或抗神经炎素，由嘧啶环和噻唑环结合而成。维生素B1能够促进血液循环，辅助盐酸制造及血流形成，有助于脑功能发挥，对能量代谢、生长、食欲、学习能力均起着积极的作用，且能够帮助人体抵抗衰老及烟酒对人体的不利影响。
(2)维生素B2：又叫核黄素，是红细胞形成、抗体制造、细胞呼吸作用及生长必须的一种维生素。能够缓解眼睛疲劳，预防白内障，辅助糖类、脂肪、蛋白质的代谢。
(3)维生素B6：是一种含吡哆醇或吡哆醛或吡哆胺的B族维生素，能够协助维持身体内钠钾平衡，促进红细胞的形成，增强机体免疫力，防止动脉硬化，阻止肾结石的形成，控制DNA的细胞增长和分裂、RNA等遗传物质的合成等。
(4)维生素B12：又叫钴胺素，主要生理功能是参与制造骨髓红细胞，防止恶性贫血，防止大脑神经受到破坏。
(5)泛酸(维生素B5)：是辅酶的重要组成元素，参与肾上腺激素的制造及抗体的形成，协助其他维生素的利用及糖类、脂肪、蛋白质能量的转化，防止贫血，维持消化道正常功能。
(6)叶酸(维生素B9)：是细胞分裂、生长不可缺少的维生素，所有生长发育或新陈代谢旺盛的组织均需要有足够的叶酸供应。供应不足，细胞的再生就受到阻碍，导致巨幼红细胞贫血；除此之外，还会引起生长不良、头发变灰、舌头发炎、肠胃不适、智力退化。孕妇缺乏叶酸可引起早产、流产及新生儿低出生体重。怀孕早期缺乏叶酸是引起胎儿神经管畸形的主要原因。另外，叶酸还能减缓老年痴呆症的发生。
(7)低聚果糖：低聚果糖除具有一般功能性低聚糖的物理化学性质外，能明显改善肠道内微生物种群比例，它是肠内双歧杆菌的活化增殖因子，可减少和抑制肠内腐败物质的产生，抑制有害细菌的生长，调节肠道内平衡；能促进微量元素铁、钙的吸收与利用，以防止骨质疏松症；可减少肝脏毒素，能在肠中生成抗癌的有机酸，有显著的防癌功能；且口味纯正香甜可口，具有类似脂肪的香味和爽口的滑腻感。
(8)柠檬酸钠：柠檬酸钠用于清凉饮料可缓和酸味，改进口味。在酿造中加入本品，可促进糖化作用。在冰糕和冰淇淋制造中，柠檬酸钠可用作乳化剂和稳定剂。柠檬酸钠还可用作乳制品的防止酸败剂，加工干酪和鱼肉制品等的增黏剂，以及食品的甜味矫正剂等。
本发明与现有技术相比，具有以下有益效果：
(1)本发明所公开的一种B族维生素组合物固体饮料营养丰富，功能多样，涵盖了人体所需的大部分B族维生素，其中的活性成分均为人体必须的物质，该复合维生素既能保健，又能提高人体抵抗力，所采用VB比例，精确设计，充分考虑了日常饮食中的正常摄取量，符合人体需要，有效提高了成人对VB的综合利用，从而提高了保健价值。
(2)口味较好，通过柠檬酸钠、低聚果糖和白砂糖等调节口味，可在不影响破坏营养的基础上有效改善味道，口感较好。
(3)本发明配方中的各种成分较为常见，容易获得，制备成本较低，适合工业化生产。
具体实施方式
为了更好地理解本发明的内容，下面结合具体实施例作进一步说明。应理解，这些实施例仅用于对本发明进一步说明，而不用于限制本发明的范围。此外应理解，在阅读了本发明所述的内容后，该领域的技术人员对本发明作出一些非本质的改动或调整，仍属于本发明的保护范围。
实施例1
在容器中里加入维生素B1 0.5mg、维生素B2 1mg、维生素B6 0.3mg、维生素B120.02mg、泛酸0.1mg、叶酸0.02mg、柠檬酸15mg、柠檬酸钠5mg、麦芽糊精0.5mg、低聚果糖7mg、白砂糖100mg。将上述各种原料按比例混合在容器中，混合均匀，既得本发明成品。
实施例2
在容器中里加入维生素B1 0.8mg、维生素B2 0.8mg、维生素B6 0.3mg、维生素B120.15mg、泛酸0.1mg、叶酸0.03mg、柠檬酸11.5mg、柠檬酸钠5mg、麦芽糊精0.5mg、低聚果糖3mg、白砂糖60mg。将上述各种原料按比例混合在容器中，混合均匀，既得本发明成品。
实施例3
在容器中里加入维生素B1 1.2mg、维生素B2 1.8mg、维生素B6 0.5mg、维生素B120.05mg、泛酸0.15mg、叶酸0.15mg、柠檬酸11.2mg、柠檬酸钠5mg、麦芽糊精0.5mg、低聚果糖5mg、白砂糖80mg。将上述各种原料按比例混合在容器中，混合均匀，既得本发明成品。
如上所述，便可以较好地实现本发明。
Claims (3)
1.一种B族维生素组合物固体饮料，其特征在于，该组合物含有以下活性成分：维生素B1、维生素B2、维生素B6、维生素B12、泛酸、叶酸、柠檬酸、柠檬酸钠、麦芽糊精、低聚果糖、白砂糖。
2.根据权利要求1所述的一种B族维生素组合物固体饮料，其特征在于，由以下重量份数的原料组成：维生素B1 0.5-1.5mg、维生素B2 0.6-1.85mg、维生素B6 0.2-0.6mg、维生素B12 0.02-0.15mg、泛酸0.1-0.25mg、叶酸0.02-0.15mg、柠檬酸11.2-19.5mg、柠檬酸钠3-8mg、麦芽糊精0.3-0.6mg、低聚果糖2-8mg、白砂糖50-120mg。
3.根据权利要求1至2任意一项所述的一种B族维生素组合物固体饮料，其特征在于，由以下重量份数的原料组成：维生素B1 0.5-1mg、维生素B2 0.8-1.2mg、维生素B6 0.2-0.5mg、维生素B12 0.02-0.06mg、泛酸0.1-0.2mg、叶酸0.02-0.04mg、柠檬酸12-15mg、柠檬酸钠4-6mg、麦芽糊精0.4-0.5mg、低聚果糖5-7mg、白砂糖80-100mg。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811555759.0A CN111328949A (zh) | 2018-12-19 | 2018-12-19 | 一种b族维生素组合物固体饮料 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811555759.0A CN111328949A (zh) | 2018-12-19 | 2018-12-19 | 一种b族维生素组合物固体饮料 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111328949A true CN111328949A (zh) | 2020-06-26 |
Family
ID=71173679
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201811555759.0A Pending CN111328949A (zh) | 2018-12-19 | 2018-12-19 | 一种b族维生素组合物固体饮料 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111328949A (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112690457A (zh) * | 2020-12-24 | 2021-04-23 | 石药集团中诺药业（泰州）有限公司 | 一种用于超重和肥胖人群的营养素组合物配方 |
-
2018
- 2018-12-19 CN CN201811555759.0A patent/CN111328949A/zh active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112690457A (zh) * | 2020-12-24 | 2021-04-23 | 石药集团中诺药业（泰州）有限公司 | 一种用于超重和肥胖人群的营养素组合物配方 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6929793B2 (en) | Nutritional composition for treating an immune condition | |
| CN102687750B (zh) | 一种减肥代餐蛋白型固体饮料 | |
| CN1237914C (zh) | 一种米乳饮料的制备方法 | |
| CN104287049A (zh) | 一种体重管理的代餐蛋白质粉固体饮料 | |
| JP2003500036A (ja) | 新規の組成物 | |
| EP2316529A1 (en) | Compositions and methods for treatment of body weight conditions with enzyme inhibiting peptides | |
| CN113412862A (zh) | 中老年配方奶粉及其制备方法 | |
| CN102550677B (zh) | 一种对中老年人具有保健功能的液态乳制品及其生产方法 | |
| CN105876585A (zh) | 蛋白质固体饮料、其制备方法及其应用 | |
| CN103432161A (zh) | 多种维生素矿物质泡腾片及其制备方法 | |
| WO2008014674A1 (fr) | Sel de potassium comestible nutritionnel et de soin ayant un large champ d'application | |
| CN106605709B (zh) | 一种适合3-6岁儿童的液态奶及其制备方法 | |
| JPH09191852A (ja) | 健康食品 | |
| CN105011154A (zh) | 一种缓解青少年视疲劳促进记忆力的组合物及其制备方法 | |
| CN103371318B (zh) | 一种膳食营养补充食品 | |
| CN101028335A (zh) | 一种核桃油保健软胶囊 | |
| JPH0272843A (ja) | 糖アルコールを含有するミネラル補給剤 | |
| CN111328949A (zh) | 一种b族维生素组合物固体饮料 | |
| JPH07222571A (ja) | 運動選手用飲食品 | |
| JPS6049775A (ja) | 栄養食品の製造法 | |
| CN114680339A (zh) | 一种改善肌肉衰减延缓衰老的营养补充剂及其应用 | |
| CN108157718A (zh) | 一种蜂蜜饮料 | |
| CN1985664A (zh) | 一种青少年专用双蛋白食品及其制备方法 | |
| KR100734944B1 (ko) | 젖산칼슘 및 미강을 주재로 한 기능성 건강식품 조성물 | |
| Novhorodska | Sour milk drink with prebiotic properties |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20200626 |
|
| WD01 | Invention patent application deemed withdrawn after publication |